| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $176K | -89.9% | -43.3% |
| SG&A Expense | $822K | -14.3% | -21.5% |
| Operating Income | -$998K | +63.0% | +26.5% |
| Interest Expense | $3K | +6.7% | -24.2% |
| Net Income | -$1.0M | +63.0% | +29.3% |
| EPS (Basic) | -$0.30 | +76.6% | +25.0% |
| EPS (Diluted) | -$0.30 | +76.6% | +25.0% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.4M | -20.8% | +8.7% |
| Current Assets | $4.7M | -20.4% | -1.0% |
| Total Assets | $5.1M | -19.5% | +1.7% |
| Total Liabilities | $717K | -27.0% | -42.8% |
| Stockholders' Equity | $4.4M | -18.1% | +16.6% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.5M | -49.6% | — |
| Investing Cash Flow | -$90K | — | — |
| Financing Cash Flow | $4.0M | +0.0% | — |